DE69715217D1 - Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes - Google Patents

Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes

Info

Publication number
DE69715217D1
DE69715217D1 DE69715217T DE69715217T DE69715217D1 DE 69715217 D1 DE69715217 D1 DE 69715217D1 DE 69715217 T DE69715217 T DE 69715217T DE 69715217 T DE69715217 T DE 69715217T DE 69715217 D1 DE69715217 D1 DE 69715217D1
Authority
DE
Germany
Prior art keywords
maintain
increase
mineral content
linoleic acid
bone mineral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69715217T
Other languages
English (en)
Other versions
DE69715217T2 (de
Inventor
E Cook
W Pariza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of DE69715217D1 publication Critical patent/DE69715217D1/de
Publication of DE69715217T2 publication Critical patent/DE69715217T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fertilizers (AREA)
DE69715217T 1996-08-07 1997-03-18 Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes Expired - Lifetime DE69715217T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/693,577 US5804210A (en) 1996-08-07 1996-08-07 Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein
PCT/US1997/004536 WO1998005318A1 (en) 1996-08-07 1997-03-18 Conjugated linoleic acid to maintain or enhance bone mineral content

Publications (2)

Publication Number Publication Date
DE69715217D1 true DE69715217D1 (de) 2002-10-10
DE69715217T2 DE69715217T2 (de) 2003-08-07

Family

ID=24785234

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715217T Expired - Lifetime DE69715217T2 (de) 1996-08-07 1997-03-18 Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes

Country Status (9)

Country Link
US (1) US5804210A (de)
EP (1) EP0920309B1 (de)
JP (1) JP2000515864A (de)
AT (1) ATE223213T1 (de)
AU (1) AU2338497A (de)
DE (1) DE69715217T2 (de)
DK (1) DK0920309T3 (de)
ES (1) ES2179319T3 (de)
WO (1) WO1998005318A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1911999A (en) * 1997-12-12 1999-06-28 Penn State Research Foundation, The Methods and compositions for treating diabetes
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
JPH11209279A (ja) * 1998-01-05 1999-08-03 Natural Ltd As 体重減少および肥満処置の方法
US7078051B1 (en) 1998-08-11 2006-07-18 Natural Asa Conjugated linoleic acid alkyl esters in feedstuffs and food
US6015833A (en) * 1998-03-17 2000-01-18 Conlinco., Inc. Conjugated linoleic acid compositions
KR100619651B1 (ko) 1998-03-17 2006-09-05 콘린코 인크. 공액 리놀레산 조성물
US7776353B1 (en) 1998-03-17 2010-08-17 Aker Biomarine Asa Conjugated linoleic acid compositions
US6077525A (en) * 1998-04-10 2000-06-20 The George Washington University Use of conjugated linoleic acids
US6696584B2 (en) 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
US6060514A (en) * 1998-05-04 2000-05-09 Conlin Co., Inc. Isomer enriched conjugated linoleic acid compositions
US6214372B1 (en) * 1998-05-04 2001-04-10 Con Lin Co., Inc. Method of using isomer enriched conjugated linoleic acid compositions
AU747057B2 (en) 1998-05-04 2002-05-09 Conlinco, Inc. Methods of using isomer enriched conjugated linoleic acid compositions
US7101914B2 (en) * 1998-05-04 2006-09-05 Natural Asa Isomer enriched conjugated linoleic acid compositions
US6071544A (en) * 1999-04-01 2000-06-06 The Iams Company Dietary compositions and method for promoting healthy weight loss cats
US7947737B1 (en) 1999-09-30 2011-05-24 Aker Biomarine Asa Method of treating hypertension and reducing serum lipase activity
GB0003310D0 (en) * 2000-02-15 2000-04-05 Univ Sheffield Bone formation
AU5144901A (en) * 2000-04-06 2001-10-23 Conlinco Inc Conjugated linoleic acid compositions
WO2001078531A2 (en) 2000-04-18 2001-10-25 Natural As Conjugated linoleic acid powder
US20030149288A1 (en) * 2000-04-18 2003-08-07 Natural Asa Conjugated linoleic acid powder
US6380409B1 (en) * 2000-04-24 2002-04-30 Conlin Co., Inc. Methods for preparing CLA isomers
EP1357977B1 (de) 2000-09-21 2004-07-21 Nutrition 21, Inc. Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils
BR0100421A (pt) * 2001-01-12 2002-09-10 Fundacao De Amparo A Pesquisa Produto para alimentação de mamìferos visando aumentar o teor e/ou produção de proteìna no leite, processo de obtenção de aumento de produção e/ou teor de proteìna no leite e processo de obtenção de leite que propicia maior rendimento e/ou qualidade dos produtos lácteos produzidos a partir deste leite
US6479683B1 (en) 2001-03-06 2002-11-12 Ag Processing Inc Process for conjugating fatty acid esters
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
US6677470B2 (en) 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
CA2396840A1 (en) * 2002-08-06 2004-02-06 Juan Miguel Garro Galvez New conjugated linolenic acids and methods for commercial preparation, purification and uses
US6743931B2 (en) 2002-09-24 2004-06-01 Natural Asa Conjugated linoleic acid compositions
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US20050154059A1 (en) * 2004-01-13 2005-07-14 Cook Mark E. Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
EP1765964A4 (de) * 2004-04-30 2007-11-07 Synthese von salzen aus mehrfach ungesättigten fettsäuren und ein- und zweiwertigen metallen
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442125A (en) * 1978-06-26 1984-04-10 Oxford Hill, Ltd. Process for detaching or preventing attachment of microorganisms to a surface
DE3519361A1 (de) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US5070104A (en) * 1989-02-17 1991-12-03 Wisconsin Alumni Research Foundation Methods of chelating metal and novel compositions therefor
US5017614A (en) * 1989-02-17 1991-05-21 Wisconsin Alumni Research Foundation Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor
US5208356A (en) * 1989-02-17 1993-05-04 Wisconsin Alumni Research Foundation Octadecadienoic phospholipic esters, antioxidant and mold inhibiting compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5428072A (en) * 1992-04-29 1995-06-27 Wisconsin Alumni Research Foundation Method of increasing the efficiency of feed conversion in animals
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
EP0585057A1 (de) * 1992-08-25 1994-03-02 Scotia Holdings Plc Lithiumsalzen von Fettsäuren zur Behandlung der viralen Infektionen und Krebs
JP3814309B2 (ja) * 1994-04-12 2006-08-30 リポプロテイン・テクノロジーズ・インコーポレイテッド 骨粗鬆症治療剤
JPH0826982A (ja) * 1994-07-15 1996-01-30 Lion Corp 骨粗鬆症予防・治療剤
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds

Also Published As

Publication number Publication date
JP2000515864A (ja) 2000-11-28
EP0920309A1 (de) 1999-06-09
ATE223213T1 (de) 2002-09-15
EP0920309B1 (de) 2002-09-04
US5804210A (en) 1998-09-08
ES2179319T3 (es) 2003-01-16
DE69715217T2 (de) 2003-08-07
WO1998005318A1 (en) 1998-02-12
AU2338497A (en) 1998-02-25
DK0920309T3 (da) 2002-12-09

Similar Documents

Publication Publication Date Title
DE69715217D1 (de) Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes
ATE281160T1 (de) Verfahren zur erhaltung von bestehenden körperfettgehalt und/oder körpergewicht
ATE229279T1 (de) Verfahren zur erhöhung der fettfestigkeit und zur verbesserung der fleischqualität bei tieren
ATE231722T1 (de) Verfahren zur vermeidung von skelettproblemen beim geflügel
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE120482T1 (de) Enzymatisches verfahren zur verminderung des gehaltes an phosphorhaltigen bestandteilen in pflanzl. u. tierischen olen.
MY101842A (en) Treatment of oral diseases.
ID23496A (id) Ekstrak tanaman untuk mengobati peningkatan resorpsi tulang
IL143488A0 (en) Cancer treatment composition and method using natural plant essential oils
ATE286392T1 (de) Photodynamische behandlung von synovium
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DE60029591D1 (de) Konjugierte linolensäure zur behandlung von cyclooxygenase-2 vermittelten entzündungen und schmerzen
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
PT2009025E (pt) Método de inibição da actividade dos osteoclastos
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
BG105275A (en) Tan-1057 derivatives
NZ512086A (en) Method of increasing fat firmness and improving meat quality in animals
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
DE69922174D1 (de) Biomaterial zur behandlung von zahnfäule
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin